TD Cowen Cuts BioNTech (NASDAQ:BNTX) Price Target to $122.00

BioNTech (NASDAQ:BNTX – Free Report) had its target price lowered by TD Cowen from $132.00 to $122.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has a hold rating on the stock. Several other equities research analysts have also issued reports on BNTX. HC Wainwright lifted their price target […]

Leave a Reply

Your email address will not be published.

Previous post Avis Budget Group (NASDAQ:CAR) Price Target Cut to $150.00 by Analysts at JPMorgan Chase & Co.
Next post Royal Bank of Canada Has Lowered Expectations for Beam Therapeutics (NASDAQ:BEAM) Stock Price